Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H31Cl2N3O4 |
InChIKeyJXZILNDFAYXEFX-UHFFFAOYSA-N |
CAS Registry144181-11-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | - | |
| Neoplasms | Preclinical | United States | - |





